Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-ALA for Visualization of Malignant Glial Tumors
NCT00977795Phase 2Withdrawn
- Sponsor
- Endeavor Health
- Start
- Sep 2009
- Primary completion
- Jan 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of 5-aminolevulinic acid in malignant glioma, sponsored by Endeavor Health. Planned start Sep 2009; status: withdrawn.
02
Drugs
5-aminolevulinic acid
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT00977795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00977795.